Related references
Note: Only part of the references are listed.RNAseq reveals extensive metabolic disruptions in the sensitive SF-295 cell line treated with schweinfurthins
J. S. Weissenrieder et al.
SCIENTIFIC REPORTS (2022)
Feedback activation of STAT3 limits the response to PI3K/AKT/mTOR inhibitors in PTEN-deficient cancer cells
Jian Wang et al.
ONCOGENESIS (2021)
Long Noncoding RNA H19: A Novel Therapeutic Target Emerging in Oncology Via Regulating Oncogenic Signaling Pathways
Baokang Wu et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Regulation of mTOR signaling by long non-coding RNA
Karam Aboudehen
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2020)
ShinyGO: a graphical gene-set enrichment tool for animals and plants
Steven Xijin Ge et al.
BIOINFORMATICS (2020)
Inhibition of PI3K by copanlisib exerts potent antitumor effects on Merkel cell carcinoma cell lines and mouse xenografts
Bin Fang et al.
SCIENTIFIC REPORTS (2020)
Clinical and molecular characterization of virus-positive and virus-negative Merkel cell carcinoma
Gabriel J. Starrett et al.
GENOME MEDICINE (2020)
Surface charge of Merkel cell polyomavirus small T antigen determines cell transformation through allosteric FBW7 WD40 domain targeting
Nnenna Nwogu et al.
ONCOGENESIS (2020)
Merkel cell polyomavirus small tumour antigen activates the p38 MAPK pathway to enhance cellular motility
Samuel J. Dobson et al.
BIOCHEMICAL JOURNAL (2020)
Long Noncoding RNA LINC01134 Promotes Hepatocellular Carcinoma Metastasis via Activating AKT1S1 and NF-κB Signaling
Chao Wang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Merkel Cell Polyomavirus Small Tumor Antigen Activates Matrix Metallopeptidase-9 Gene Expression for Cell Migration and Invasion
Nnenna Nwogu et al.
JOURNAL OF VIROLOGY (2020)
Merkel Cell Polyomavirus Small T Antigen Activates Noncanonical NF-κB Signaling to Promote Tumorigenesis
Jiawei Zhao et al.
MOLECULAR CANCER RESEARCH (2020)
Long Non-Coding RNAs: The Regulatory Mechanisms, Research Strategies, and Future Directions in Cancers
Na Gao et al.
FRONTIERS IN ONCOLOGY (2020)
Navitoclax combined with Alpelisib effectively inhibits Merkel cell carcinoma cell growth in vitro
Emil Chteinberg et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)
Characterization of six Merkel cell polyomavirus-positive Merkel cell carcinoma cell lines: Integration pattern suggest that large T antigen truncating events occur before or during integration
David Schrama et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Characterizing the Therapeutic Potential of a Potent BET Degrader in Merkel Cell Carcinoma
Jae Eun Choi et al.
NEOPLASIA (2019)
Advances in the Understanding of Skin Cancer: Ultraviolet Radiation, Mutations, and Antisense Oligonucleotides as Anticancer Drugs
Kateryna V. Laikova et al.
MOLECULES (2019)
3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs
Ana S. Nunes et al.
BIOTECHNOLOGY AND BIOENGINEERING (2019)
Schweinfurthin natural products induce regression of murine melanoma and pair with anti-PD-1 therapy to facilitate durable tumor immunity
Kathleen M. Kokolus et al.
ONCOIMMUNOLOGY (2019)
5-methylschweinfurthin G reduces chondrosarcoma tumor growth
Jeff W. Stevens et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2018)
Merkel Cell Polyomavirus Small T Antigen Drives Cell Motility via Rho-GTPase-Induced Filopodium Formation
Gabriele Stakaityte et al.
JOURNAL OF VIROLOGY (2018)
Merkel cell carcinoma: Current US incidence and projected increases based on changing demographics
Kelly G. Paulson et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Phosphatidylinositol 3-kinase p110δ expression in Merkel cell carcinoma
Emil Chteinberg et al.
Oncotarget (2018)
Schweinfurthins A-Q: isolation, synthesis, and biochemical properties
Dipesh S. Harmalkar et al.
RSC ADVANCES (2018)
Cellular sheddases are induced by Merkel cell polyomavirus small tumour antigen to mediate cell dissociation and invasiveness
Nnenna Nwogu et al.
PLOS PATHOGENS (2018)
iDEP: an integrated web application for differential expression and pathway analysis of RNA-Seq data
Steven Xijin Ge et al.
BMC BIOINFORMATICS (2018)
Schweinfurthins: Lipid Modulators with Promising Anticancer Activity
Emily J. Koubek et al.
LIPIDS (2018)
Systematic literature review of efficacy, safety and tolerability outcomes of chemotherapy regimens in patients with metastatic Merkel cell carcinoma
Paul Nghiem et al.
FUTURE ONCOLOGY (2017)
Discovery of a highly selective chemical inhibitor of matrix metalloproteinase-9 (MMP-9) that allosterically inhibits zymogen activation
Robert H. Scannevin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Merkel cell polyomavirus small T antigen induces genome instability by E3 ubiquitin ligase targeting
H. J. Kwun et al.
ONCOGENE (2017)
Is this the end of cytotoxic chemotherapy in Merkel cell carcinoma?
Guilherme Rabinowits
ONCOTARGETS AND THERAPY (2017)
Merkel Cell Polyomavirus Small T Antigen Initiates Merkel Cell Carcinoma-like Tumor Development in Mice
Monique E. Verhaegen et al.
CANCER RESEARCH (2017)
Frequency and locations of systemic metastases in Merkel cell carcinoma by imaging
Maria Kouzmina et al.
ACTA RADIOLOGICA OPEN (2017)
Dual mTOR inhibitor MLN0128 suppresses Merkel cell carcinoma (MCC) xenograft tumor growth
Aarthi Kannan et al.
ONCOTARGET (2016)
Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy
Gerald Goh et al.
ONCOTARGET (2016)
Next generation sequencing of Cytokeratin 20-negative Merkel cell carcinoma reveals ultraviolet-signature mutations and recurrent TP53 and RB1 inactivation
Paul W. Harms et al.
MODERN PATHOLOGY (2016)
Small molecule schweinfurthins selectively inhibit cancer cell proliferation and mTOR/AKT signaling by interfering with trans-Golgi-network trafficking
Xingfeng Bao et al.
CANCER BIOLOGY & THERAPY (2015)
UV-Associated Mutations Underlie the Etiology of MCV-Negative Merkel Cell Carcinomas
Stephen Q. Wong et al.
CANCER RESEARCH (2015)
Merkel Cell Polyomavirus Small T Antigen Is Oncogenic in Transgenic Mice
Monique E. Verhaegen et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Restricted Protein Phosphatase 2A Targeting by Merkel Cell Polyomavirus Small T Antigen
Hyun Jin Kwun et al.
JOURNAL OF VIROLOGY (2015)
Effect of the dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 against human Merkel cell carcinoma MKL-1 cells
Zhenyu Lin et al.
ONCOLOGY LETTERS (2015)
Merkel Cell Polyomavirus Small T Antigen Mediates Microtubule Destabilization To Promote Cell Motility and Migration
Laura M. Knight et al.
JOURNAL OF VIROLOGY (2015)
Chronic mTOR activation promotes cell survival in Merkel cell carcinoma
Zhenyu Lin et al.
CANCER LETTERS (2014)
Quantitative analysis of F-actin redistribution in astrocytoma cells treated with candidate pharmaceuticals
Stephen Lockett et al.
CYTOMETRY PART A (2014)
Cisplatin in cancer therapy: Molecular mechanisms of action
Shaloam Dasari et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Merkel Cell Carcinoma Dependence on Bcl-2 Family Members for Survival
Monique E. Verhaegen et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Merkel cell carcinoma of the hand and upper extremity: Current trends and outcomes
Ali M. Soltani et al.
JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY (2014)
Merkel Cell Polyomavirus Small T Antigen Controls Viral Replication and Oncoprotein Expression by Targeting the Cellular Ubiquitin Ligase SCFFbw7
Hyun Jin Kwun et al.
CELL HOST & MICROBE (2013)
Merkel Cell Carcinoma: A Virus-Induced Human Cancer
Yuan Chang et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 7 (2012)
Activation of PI3K Signaling in Merkel Cell Carcinoma
Valentina Nardi et al.
CLINICAL CANCER RESEARCH (2012)
Activation of the PI3K/AKT Pathway in Merkel Cell Carcinoma
Christian Hafner et al.
PLOS ONE (2012)
Functional Evaluation of a Fluorescent Schweinfurthin: Mechanism of Cytotoxicity and Intracellular Quantification
Craig H. Kuder et al.
MOLECULAR PHARMACOLOGY (2012)
Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator
Masahiro Shuda et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Natural products for cancer chemotherapy
Arnold L. Demain et al.
MICROBIAL BIOTECHNOLOGY (2011)
Merkel Cell Carcinoma: Incidence, Mortality, and Risk of Other Cancers
Jeanette Kaae et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Schweinfurthin A Selectively Inhibits Proliferation and Rho Signaling in Glioma and Neurofibromatosis Type 1 Tumor Cells in a NF1-GRD-Dependent Manner
Thomas J. Turbyville et al.
MOLECULAR CANCER THERAPEUTICS (2010)
BF3•Et2O-mediated cascade cyclizations:: Synthesis of schweinfurthins F and G
Nolan R. Mente et al.
JOURNAL OF ORGANIC CHEMISTRY (2008)
Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients:: the AEIOU features
Michelle Heath et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
Clonal integration of a polyomavirus in human Merkel cell carcinoma
Huichen Feng et al.
SCIENCE (2008)
Targeting dual-specificity phosphatases: manipulating MAP kinase signalling and immune responses
Kate L. Jeffrey et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Synthesis and structure-activity studies of schweinfurthin B analogs: Evidence for the importance of a D-ring hydrogen bond donor in expression of differential cytotoxicity
JD Neighbors et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
mTOR-dependent suppression of protein phosphatase 2A is critical for phospholipase D survival signals in human breast cancer cells
L Hui et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Synthesis of nonracemic 3-deoxyschweinfurthin B
JD Neighbors et al.
JOURNAL OF ORGANIC CHEMISTRY (2005)
A cascade cyclization approach to schweinfurthin B
EM Treadwell et al.
ORGANIC LETTERS (2002)
Share Paper
